Hikma Pharmaceuticals PLC (LON:HIK)
1,740.00
-10.00 (-0.57%)
Aug 8, 2025, 5:35 PM BST
Hikma Pharmaceuticals Employees
Hikma Pharmaceuticals had 9,500 employees as of December 31, 2024. The number of employees increased by 400 or 4.40% compared to the previous year.
Employees
9,500
Change (1Y)
400
Growth (1Y)
4.40%
Revenue / Employee
$247,090
Profits / Employee
$28,505
Market Cap
3.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9,500 | 400 | 4.40% |
Dec 31, 2023 | 9,100 | 300 | 3.41% |
Dec 31, 2022 | 8,800 | 100 | 1.15% |
Dec 31, 2021 | 8,700 | 100 | 1.16% |
Dec 31, 2020 | 8,600 | 0 | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Genus | 3,500 |
Hikma Pharmaceuticals News
- 11 hours ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript - Seeking Alpha
- 1 day ago - Hikma Pharmaceuticals PLC 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript - Seeking Alpha
- 2 days ago - Hikma Pharmaceuticals tumbles after injectables margin outlook cut - Reuters
- 16 days ago - Hikma Pharmaceuticals: a quality compounder waiting for a catalyst - The Armchair Trader
- 5 weeks ago - Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US - PRNewsWire
- 5 weeks ago - Hikma Pharmaceuticals to invest $1B by 2030 to expand US manufacturing, R&D - Seeking Alpha
- 6 weeks ago - Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PRNewsWire